Analysis of multicenter clinical trials with very low event rates.

Binary outcomes GEE Low event rate Mantel–Haenszel Multicenter trial Random effects Randomized clinical trial Small sample adjustment Stratified randomization

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
09 Nov 2020
Historique:
received: 29 01 2020
accepted: 10 10 2020
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 22 6 2021
Statut: epublish

Résumé

In a five-arm randomized clinical trial (RCT) with stratified randomization across 54 sites, we encountered low primary outcome event proportions, resulting in multiple sites with zero events either overall or in one or more study arms. In this paper, we systematically evaluated different statistical methods of accounting for center in settings with low outcome event proportions. We conducted a simulation study and a reanalysis of a completed RCT to compare five popular methods of estimating an odds ratio for multicenter trials with stratified randomization by center: (i) no center adjustment, (ii) random intercept model, (iii) Mantel-Haenszel model, (iv) generalized estimating equation (GEE) with an exchangeable correlation structure, and (v) GEE with small sample correction (GEE-small sample correction). We varied the number of total participants (200, 500, 1000, 5000), number of centers (5, 50, 100), control group outcome percentage (2%, 5%, 10%), true odds ratio (1, > 1), intra-class correlation coefficient (ICC) (0.025, 0.075), and distribution of participants across the centers (balanced, skewed). Mantel-Haenszel methods generally performed poorly in terms of power and bias and led to the exclusion of participants from the analysis because some centers had no events. Failure to account for center in the analysis generally led to lower power and type I error rates than other methods, particularly with ICC = 0.075. GEE had an inflated type I error rate except in some settings with a large number of centers. GEE-small sample correction maintained the type I error rate at the nominal level but suffered from reduced power and convergence issues in some settings when the number of centers was small. Random intercept models generally performed well in most scenarios, except with a low event rate (i.e., 2% scenario) and small total sample size (n ≤ 500), when all methods had issues. Random intercept models generally performed best across most scenarios. GEE-small sample correction performed well when the number of centers was large. We do not recommend the use of Mantel-Haenszel, GEE, or models that do not account for center. When the expected event rate is low, we suggest that the statistical analysis plan specify an alternative method in the case of non-convergence of the primary method.

Identifiants

pubmed: 33168073
doi: 10.1186/s13063-020-04801-5
pii: 10.1186/s13063-020-04801-5
pmc: PMC7654615
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

917

Subventions

Organisme : Medical Research Council
ID : MC_UU_12023/21
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R00 HL141678
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL143289
Pays : United States

Références

BMC Med Res Methodol. 2016 Aug 30;16(1):113
pubmed: 27576307
N Engl J Med. 2018 Jun 14;378(24):2302-2310
pubmed: 29791259
Control Clin Trials. 1998 Jun;19(3):249-56
pubmed: 9620808
Biometrics. 2001 Mar;57(1):126-34
pubmed: 11252587
BMC Med Res Methodol. 2014 Feb 10;14:20
pubmed: 24512175
Stat Med. 2000 Apr 30;19(8):1115-39
pubmed: 10790684
Stat Med. 2015 Jan 30;34(2):281-96
pubmed: 25345738
Stat Med. 2012 Feb 20;31(4):328-40
pubmed: 22139891
Stat Med. 2002 Aug 30;21(16):2409-19
pubmed: 12210625
Trials. 2016 Sep 06;17(1):438
pubmed: 27600609
Biometrics. 2001 Dec;57(4):1198-206
pubmed: 11764261
Stat Med. 2019 May 20;38(11):2074-2102
pubmed: 30652356
Trials. 2017 Nov 2;18(1):512
pubmed: 29096682

Auteurs

Jiyu Kim (J)

Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.

Andrea B Troxel (AB)

Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.

Scott D Halpern (SD)

Palliative and Advanced Illness Research (PAIR) Center, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 304 Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104-6021, USA.
Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Center for Health Incentives and Behavioral Economics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Kevin G Volpp (KG)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Center for Health Incentives and Behavioral Economics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Philadelphia VA Medical Center, Philadelphia, PA, USA.
Department of Health Care Management, Wharton School, University of Pennsylvania, Philadelphia, PA, USA.

Brennan C Kahan (BC)

MRC Clinical Trials Unit at UCL, London, UK.

Tim P Morris (TP)

MRC Clinical Trials Unit at UCL, London, UK.
Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Michael O Harhay (MO)

Palliative and Advanced Illness Research (PAIR) Center, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 304 Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104-6021, USA. mharhay@pennmedicine.upenn.edu.
Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mharhay@pennmedicine.upenn.edu.
Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mharhay@pennmedicine.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH